NCT02468063View on ClinicalTrials.gov

To Assess the Efficacy of Early Introduction of a Combination of Low Dose Vasopressin Analogue in Addition to Noradrenaline as a Vasopressor in Patients of Cirrhosis With Septic Shock

NACompletedINTERVENTIONAL

Enrollment

184

Participants

Timeline

Start Date

May 1, 2015

Primary Completion Date

May 31, 2017

Study Completion Date

May 31, 2017

Conditions

Cirrhosis With Septic Shock

Interventions

DRUG

Low dose terlipressin

Terlipressin-2mg (low dose )

DRUG

Noradrenaline

Noradrenaline at 7.5 mcg/min, maximum of 60mcg/min. stepped up every 15 min

DRUG

Noradrenaline

Noradrenaline- 3.75 mcg/min to 30 mcg/min. stepped up every 15 min

Trial Locations (1)

110070

Institute of Liver and Biliary Sciences, New Delhi

All Listed Sponsors

lead

Institute of Liver and Biliary Sciences, India

OTHER

NCT02468063 - To Assess the Efficacy of Early Introduction of a Combination of Low Dose Vasopressin Analogue in Addition to Noradrenaline as a Vasopressor in Patients of Cirrhosis With Septic Shock | Biotech Hunter | Biotech Hunter